X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (887) 887
Publication (100) 100
Book Review (4) 4
Dissertation (3) 3
Magazine Article (2) 2
Newsletter (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (692) 692
melioidosis (516) 516
melioidosis - drug therapy (493) 493
male (393) 393
index medicus (365) 365
burkholderia pseudomallei (309) 309
infectious diseases (275) 275
female (266) 266
melioidosis - diagnosis (266) 266
melioidosis - microbiology (263) 263
anti-bacterial agents - therapeutic use (249) 249
adult (242) 242
microbiology (236) 236
middle aged (229) 229
burkholderia pseudomallei - isolation & purification (224) 224
pseudomonas infections (163) 163
animals (156) 156
burkholderia pseudomallei - drug effects (146) 146
immunology (131) 131
bacteria (129) 129
antibiotics (128) 128
infections (127) 127
melioidosis - epidemiology (121) 121
melioidosis - complications (120) 120
ceftazidime (118) 118
burkholderia-pseudomallei (116) 116
aged (113) 113
pseudomonas-pseudomallei (107) 107
mortality (103) 103
anti-bacterial agents - pharmacology (97) 97
burkholderia (97) 97
microbial sensitivity tests (97) 97
diagnosis (96) 96
treatment outcome (96) 96
thailand (95) 95
research article (93) 93
epidemiology (91) 91
health aspects (90) 90
burkholderia pseudomallei - genetics (88) 88
adolescent (87) 87
medicine (87) 87
ceftazidime - therapeutic use (86) 86
mice (85) 85
risk factors (85) 85
tropical medicine (84) 84
bacterial infections and mycoses (82) 82
burkholderia pseudomallei - pathogenicity (80) 80
infection (78) 78
australia (75) 75
melioidosis - pathology (75) 75
pharmacology & pharmacy (74) 74
research (70) 70
sepsis (69) 69
diagnosis, differential (66) 66
care and treatment (64) 64
medicine, general & internal (64) 64
child (63) 63
pneumonia (63) 63
travel (59) 59
trimethoprim, sulfamethoxazole drug combination - therapeutic use (59) 59
drug therapy, combination (58) 58
melioidosis - mortality (57) 57
analysis (49) 49
diabetes (49) 49
mice, inbred balb c (49) 49
resistance (49) 49
anti-bacterial agents - administration & dosage (47) 47
disease models, animal (47) 47
child, preschool (46) 46
virulence (46) 46
infectious and parasitic diseases (45) 45
melioidosis - immunology (43) 43
public, environmental & occupational health (43) 43
drug therapy (42) 42
parasitology (42) 42
burkholderia pseudomallei - immunology (40) 40
retrospective studies (40) 40
tomography, x-ray computed (39) 39
antimicrobial agents (38) 38
bacterial infections (38) 38
identification (38) 38
patients (38) 38
susceptibility (38) 38
drug therapy, combination - therapeutic use (37) 37
bacterial diseases (36) 36
pseudomallei (36) 36
melioidosis - diagnostic imaging (35) 35
prospective studies (35) 35
thienamycins - therapeutic use (35) 35
tuberculosis (35) 35
disease (34) 34
doxycycline (34) 34
recurrence (34) 34
therapy (34) 34
biochemical phenomena, metabolism, and nutrition (33) 33
india (33) 33
melioidosis - prevention & control (33) 33
multidisciplinary sciences (33) 33
young adult (33) 33
arctic medicine. tropical medicine (32) 32
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (854) 854
French (11) 11
German (7) 7
Russian (7) 7
Japanese (6) 6
Chinese (3) 3
Danish (3) 3
Dutch (2) 2
Icelandic (1) 1
Portuguese (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug Resistance Updates, ISSN 1368-7646, 2016, Volume 28, pp. 82 - 90
Abstract The genus Burkholderia comprises metabolically diverse and adaptable Gram-negative bacteria, which thrive in often adversarial environments. A few... 
Infectious Disease | Hematology, Oncology and Palliative Medicine | Melioidosis | Glanders | Burkholderia | Antibiotics resistance | Burkholderia cepacia complex | OPRB EFFLUX PUMP | DRUG-RESISTANCE | GYRASE GYRA GENE | BPEAB-OPRB | GRAM-NEGATIVE BACTERIA | CYSTIC-FIBROSIS PATIENTS | PSEUDOMONAS-AERUGINOSA | PHARMACOLOGY & PHARMACY | BETA-LACTAMASES | CEPACIA COMPLEX | IN-VITRO ACTIVITY | Burkholderia mallei - drug effects | Humans | Porins - metabolism | Burkholderia mallei - genetics | Burkholderia - pathogenicity | Porins - antagonists & inhibitors | Burkholderia pseudomallei - drug effects | Burkholderia pseudomallei - growth & development | Burkholderia Infections - pathology | Burkholderia pseudomallei - pathogenicity | Burkholderia mallei - growth & development | Burkholderia pseudomallei - genetics | Melioidosis - microbiology | Burkholderia Infections - microbiology | Burkholderia - drug effects | Glanders - drug therapy | Burkholderia - genetics | Porins - genetics | Genes, MDR | Glanders - pathology | Bacterial Proteins - genetics | Tetrahydrofolate Dehydrogenase - metabolism | DNA Gyrase - metabolism | Melioidosis - pathology | Animals | Burkholderia mallei - pathogenicity | DNA Gyrase - genetics | Melioidosis - drug therapy | Burkholderia Infections - drug therapy | Glanders - microbiology | Horses | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Gene Expression Regulation, Bacterial | Burkholderia - growth & development | Tetrahydrofolate Dehydrogenase - genetics | Medical colleges | Drug resistance in microorganisms | Cystic fibrosis | Bacteria | Beta lactamases | Dihydrofolate reductase | Antibacterial agents | glanders | melioidosis | antibiotics resistance
Journal Article
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 2012, Volume 18, Issue 12, p. e2
Journal Article
The Lancet, ISSN 0140-6736, 05/2003, Volume 361, Issue 9370, pp. 1715 - 1722
Melioidosis, which is infection with the gram-negative bacterium , is an important cause of sepsis in east Asia and northern Australia. In northeastern... 
PSEUDOMONAS-PSEUDOMALLEI | MEDICINE, GENERAL & INTERNAL | TUMOR-NECROSIS-FACTOR | TROPICAL NORTHERN AUSTRALIA | NEUROLOGICAL MELIOIDOSIS | MAINTENANCE TREATMENT | BURKHOLDERIA-PSEUDOMALLEI | CEFTAZIDIME PLUS COTRIMOXAZOLE | BETA-LACTAM ANTIBIOTICS | COMMUNITY-ACQUIRED SEPTICEMIA | RAPID IDENTIFICATION | Encephalitis - epidemiology | Administration, Oral | Comorbidity | Doxycycline - therapeutic use | Melioidosis - epidemiology | Humans | Infusions, Parenteral | Drug Therapy, Combination - therapeutic use | Parotitis - epidemiology | Randomized Controlled Trials as Topic | Pregnancy | Melioidosis - drug therapy | Ceftazidime - administration & dosage | Pregnancy Complications, Infectious - drug therapy | Melioidosis - diagnosis | Adult | Female | Child | Melioidosis - microbiology | Drug Resistance | Pseudomonas infections | Causes of | Bacterial infections | Demographic aspects | Complications | Disease | Microbiology | Bacteria | Health care | Substance abuse treatment | Laboratories | Brain stem | Liver | Trimethoprim | Infections | Trimethoprim-sulfamethoxazole | Sulfamethoxazole | Conflicts of interest | Children | Burkholderia | Ceftazidime | Spleen | Encephalitis | Diabetes mellitus | Muscles | Chloramphenicol | Patients | Fever | Skeletal muscle | Chloromycetin | Melioidosis | Hospitals | Antibiotics | Lungs | Abscesses | Doxycycline | Amoxicillin | Sepsis | Adults | Diagnostic systems | Prostate
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9919, pp. 807 - 814
Journal Article